Press release
Ovarian Cancer Drugs Market Trends, Industry Analysis and Forecast - 2025
Ovarian Cancer Drugs Market
Get Sample Copy of Ovarian Cancer Drugs Market at: https://www.omrglobal.com/request-sample/ovarian-cancer-drugs-market-size
The major players contributing to the growth of the global ovarian cancer drugs market include AstraZeneca PLC, Clovis Oncology, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co., Inc., Eli Lilly and Co., Bristol-Myers Squibb Co., and ImmunoGen Inc.
Drug development and pipeline product
Continuous innovation in drug development and technological advancement in different therapies, such as immunotherapy and chemotherapy are expected to drive the growth of the global ovarian cancer market. Immunotherapy has less toxicity than chemotherapy which makes it more suitable for the elderly population, along with this, it shows a rapid and sustained response as compared to chemotherapy. The research institutes present in the market are focused on developing innovative treatment solutions for ovarian cancer. For instance, the Cancer Research Institute (CRI) has dedicated more than $21 million in grant funding to discover and develop effective immunotherapies to treat ovarian cancer.
For More Information, get A full report of Ovarian Cancer Drugs Market is available at: https://www.omrglobal.com/industry-reports/ovarian-cancer-drugs-market-size
Growing market opportunities in emerging economies
The consistent demand for improved healthcare infrastructure in emerging economies, such as India and China, is encouraging the development and adoption of innovative cancer treatment technologies, such as immunotherapy and hormonal therapy. One of the major factors that enhance infrastructure in any region or economy is an investment made by foreign bodies. Many institutional investors are interested in gaining exposure to these emerging economies across healthcare sector. For instance, Abraaj Group, a UAE-based private equity firm is investing around $1 billion in healthcare facilities across the emerging economies of Asia and Africa. Many emerging economies are working to improve their healthcare infrastructure by importing technologically advanced products and other laboratory devices from other countries.
Growing prevalence of Ovarian cancer
Global ovarian cancer drugs market is witnessing significant growth due to the increasing prevalence of ovarian cancer across the globe. Ovarian cancer is the eighth most commonly occurring cancer in women and the 18th most commonly prevailing cancer among all cancer type, as per the World Cancer Research Fund (WCRF). Moreover, in 2018, there were nearly 300,000 new cases of ovarian cancer registered across the globe. The rising incidence of ovarian cancer across the developed and emerging countries, are contributing to the growth of the market as there is an increasing demand for treatment drugs for ovarian cancer.
Global Ovarian Cancer Drugs Market- Segmentation
By Drug Class
• PARP Inhibitors
• Angiogenesis Inhibitors
• PD-L1 Inhibitors
By Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Others (Hormonal Therapy)
Global Ovarian Cancer Drugs Market– Segment by Region
North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/ovarian-cancer-drugs-market-size
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Drugs Market Trends, Industry Analysis and Forecast - 2025 here
News-ID: 2094110 • Views: …
More Releases from Orion Market Research
North American Cardiovascular Devices Market to Witness Growth Acceleration by 2 …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more…
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance,
• In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for…
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast …
The global surgical retractors market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The increasing research and development activities for the development of new and advanced medical devices by the pharmaceutical and biotechnology companies. Increasing demand for the new surgical devices by the end-users are key factors that are contributing to the growth of the surgical retractors market. For instance,
• In June 2022, U.S.…
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global medical packaging market is anticipated to grow with a significant CAGR of 6.1% during the forecast period. The growth of the medical packaging market is attributed to the rapidly changing healthcare industry. The medical packaging market is continuously experiencing various changes owing to the outbreak of new diseases, increasing regulatory norms, and growth in advanced healthcare systems. Furthermore, increasing development in diagnostics, pathological and other allied medical equipment…
More Releases for Ovarian
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape.
Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms…
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017"
Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150
In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United…
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.
Ovarian Cancer - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may occur in different…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
